All Stories

  1. Optimized Method for the Use of Polyethylene Glycol as Embedding Medium for Histological Studies

    Article • Morphology, May 2025, ECO-Vector LLC

    Vasily N Sukhorukov

  2. Analysis of Mutational Burden of Mitochondrial Genome in Cells of Different Human Organs and Tissues

    Article • Current Medicinal Chemistry, May 2025, Bentham Science Publishers

    Vasily N Sukhorukov

  3. Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

    Article • Current Medicinal Chemistry, December 2024, Bentham Science Publishers

    Vasily N Sukhorukov

  4. Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research

    Article • Current Medicinal Chemistry, October 2024, Bentham Science Publishers

    Vasily N Sukhorukov

  5. Rheumatoid Arthritis: What Inflammation Do We Face?

    Article • Journal of Molecular Pathology, October 2024, MDPI AG

    Vasily N Sukhorukov

  6. Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update

    Article • Current Topics in Medicinal Chemistry, October 2024, Bentham Science Publishers

    Siarhei Dabravolski, Vasily N Sukhorukov

  7. Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential

    Article • Diseases, September 2024, MDPI AG

    Vasily N Sukhorukov

  8. Vitamin D in Primary Sjogren’s Syndrome (pSS) and the Identification of Novel Single-Nucleotide Polymorphisms Involved in the Development of pSS-Associated Diseases

    Article • Diagnostics, September 2024, MDPI AG

    Vasily N Sukhorukov

  9. Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases

    Article • Journal of Molecular Pathology, August 2024, MDPI AG

    Vasily N Sukhorukov

  10. Molecular Aspects of Inflammation and Lipid Metabolism in Health and Disease: The Role of the Mitochondria

    Article • International Journal of Molecular Sciences, June 2024, MDPI AG

    Vasily N Sukhorukov

  11. Cholesteryl Ester Transfer Protein Variations and Cardiovascular Diseases

    Article • Current Pharmaceutical Design, March 2024, Bentham Science Publishers

    Vasily N Sukhorukov, Siarhei Dabravolski

  12. Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy

    Article • Journal of Lipid and Atherosclerosis, January 2024, XMLink

    Vasily N Sukhorukov

  13. Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?

    Article • Biomedicines, August 2023, MDPI AG

    Vasily N Sukhorukov

  14. Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease

    Article • Pharmaceuticals, August 2023, MDPI AG

    Vasily N Sukhorukov

  15. Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential

    Article • Molecules, July 2023, MDPI AG

    Vasily N Sukhorukov

  16. Atheroprotective Aspects of Heat Shock Proteins

    Article • International Journal of Molecular Sciences, July 2023, MDPI AG

    Vasily N Sukhorukov

  17. Oligosaccharides as Potential Therapeutics against Atherosclerosis

    Article • Molecules, July 2023, MDPI AG

    Vasily N Sukhorukov

  18. The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment

    Article • Biomedicines, July 2023, MDPI AG

    Vasily N Sukhorukov

  19. Condition “Vasa Vasorum” in Patients with Thoracic Aortic Aneurysm

    Article • Journal of Clinical Medicine, May 2023, MDPI AG

    Vasily N Sukhorukov

  20. Impaired Mitochondrial Function in T-Lymphocytes as a Result of Exposure to HIV and ART

    Article • Cells, April 2023, MDPI AG

    Vasily N Sukhorukov

  21. HDL-Based Therapy: Vascular Protection at All Stages

    Article • Biomedicines, February 2023, MDPI AG

    Vasily N Sukhorukov

  22. Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?

    Article • Cells, February 2023, MDPI AG

    Vasily N Sukhorukov

  23. Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing

    Article • Biomedicines, February 2023, MDPI AG

    Vasily N Sukhorukov

  24. Proprotein Convertase Subtilisin/Kexin 9 as a Modifier of Lipid Metabolism in Atherosclerosis

    Article • Biomedicines, February 2023, MDPI AG

    Vasily N Sukhorukov

  25. The Role of Macrophages in the Pathogenesis of Atherosclerosis

    Article • Cells, February 2023, MDPI AG

    Vasily N Sukhorukov

  26. Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis

    Article • Journal of Lipid and Atherosclerosis, January 2023, XMLink

    Vasily N Sukhorukov

  27. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis

    Article • Brazilian Journal of Medical and Biological Research, January 2023, FapUNIFESP (SciELO)

    Vasily N Sukhorukov

  28. Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Vasily N Sukhorukov

  29. Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis

    Article • International Journal of Molecular Sciences, October 2022, MDPI AG

    Vasily N Sukhorukov

  30. Effect of Glucose Levels on Cardiovascular Risk

    Article • Cells, September 2022, MDPI AG

    Vasily N Sukhorukov

  31. Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)

    Article • Biomedicines, August 2022, MDPI AG

    Vasily N Sukhorukov

  32. From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Vasily N Sukhorukov

  33. The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy

    Article • International Journal of Molecular Sciences, July 2022, MDPI AG

    Vasily N Sukhorukov

  34. Aging of Vascular System Is a Complex Process: The Cornerstone Mechanisms

    Article • International Journal of Molecular Sciences, June 2022, MDPI AG

    Vasily N Sukhorukov

  35. Interplay between Zn2+ Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing

    Article • International Journal of Molecular Sciences, June 2022, MDPI AG

    Vasily N Sukhorukov

  36. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis

    Article • International Journal of Molecular Sciences, January 2022, MDPI AG

    Vasily N Sukhorukov

  37. Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis

    Article • International Journal of Molecular Sciences, January 2022, MDPI AG

    Vasily N Sukhorukov

  38. Molecular Pathogenesis and the Possible Role of Mitochondrial Heteroplasmy in Thoracic Aortic Aneurysm

    Article • Life, December 2021, MDPI AG

    Vasily N Sukhorukov

  39. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Prof Marcello Ciaccio, anca mihaela PANTEA STOIAN, Vasily N Sukhorukov, Alexander Orekhov

  40. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis, and Treatment of Global Diseases

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Vasily N Sukhorukov

  41. The role of endoplasmic reticulum stress in atherosclerosis

    Article • Complex Issues of Cardiovascular Diseases, December 2020, NII KPSSZ

    Vasily N Sukhorukov

  42. Thoracic Aortic Aneurysm and Factors Affecting Aortic Dissection

    Article • Journal of Personalized Medicine, October 2020, MDPI AG

    Vasily N Sukhorukov

  43. Lipid Metabolism in Macrophages: Focus on Atherosclerosis

    Article • Biomedicines, August 2020, MDPI AG

    Vasily N Sukhorukov

  44. Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response

    Article • Biomedicines, July 2020, MDPI AG

    Vasily N Sukhorukov

  45. Cell and tissue markers of atherosclerosis

    Article • Complex Issues of Cardiovascular Diseases, June 2020, NII KPSSZ

    Vasily N Sukhorukov

  46. Cholesterol metabolism in macrophages

    Article • Complex Issues of Cardiovascular Diseases, June 2020, NII KPSSZ

    Vasily N Sukhorukov

  47. Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response—What is First?

    Article • International Journal of Molecular Sciences, April 2020, MDPI AG

    Vasily N Sukhorukov

  48. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis

    Article • Cells, March 2020, MDPI AG

    Vasily N Sukhorukov

  49. Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Vasily N Sukhorukov

  50. Atherosclerosis prevention the role of special diets and functional food

    Article • Frontiers in Bioscience-Elite, January 2020, Frontiers in Bioscience

    Vasily N Sukhorukov

  51. Prevention of atherosclerosis the role of special diets and functional foods

    Article • January 2020, Frontiers in Bioscience

    Vasily N Sukhorukov

  52. Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima

    Article • Biomolecules, September 2019, MDPI AG

    Vasily N Sukhorukov

  53. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part II

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  54. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part I

    Article • Current Pharmaceutical Design, May 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  55. Transcriptional Characteristics of Activated Macrophages

    Article • Current Pharmaceutical Design, May 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  56. Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, May 2019, Elsevier

    Vasily N Sukhorukov

  57. The role of physical activity in the development of atherosclerotic lesions of the vascular wall

    Article • CLINICAL AND EXPERIMENTAL MORPHOLOGY, January 2019, FSBSI Research Institute of Human Morphology

    Vasily N Sukhorukov

  58. Translation of Basic Research into Clinical Practice: Focus on Cell-Based Diagnostics and Therapy

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  59. Diagnostics and Therapy of Human Diseases - Focus on Sialidases

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  60. Current Approaches to Diagnostics and Therapies of Chronic Diseases: Focus on Molecular and Cell Biology

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Alexander Orekhov, Vasily N Sukhorukov

  61. HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages

    Article • Experimental and Molecular Pathology, October 2018, Elsevier

    Vasily N Sukhorukov

  62. Sialidases: Therapeutic and Antiatherogenic Potential

    Article • Current Pharmaceutical Design, December 2017, Bentham Science Publishers

    Mr Emile R Zakiev, Vasily N Sukhorukov, Alexander Orekhov

  63. HDL-Targeting Therapeutics: Past, Present and Future

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Vasily N Sukhorukov, Anatol Kontush

  64. Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients'; Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity

    Article • Current Pharmaceutical Design, March 2017, Bentham Science Publishers

    Vasily N Sukhorukov

  65. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, February 2017, Elsevier

    Vasily N Sukhorukov

  66. Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein

    Article • International Journal of Angiology, December 2016, Thieme Publishing Group

    Vasily N Sukhorukov

  67. Carbohydrate composition of circulating multiple-modified low-density lipoprotein

    Article • Vascular Health and Risk Management, October 2016, Dove Medical Press

    Vasily N Sukhorukov, Mr Emile R Zakiev, Alexander Orekhov

  68. Lipid composition of circulating multiple-modified low density lipoprotein

    Article • Lipids in Health and Disease, August 2016, Springer Science + Business Media

    Vasily N Sukhorukov

  69. Epigenetic factors in atherogenesis: MicroRNA

    Article • Biochemistry (Moscow) Supplement Series B Biomedical Chemistry, July 2016, Pleiades Publishing Ltd

    Vasily N Sukhorukov

  70. Epigenetic factors in atherogenesis: microRNA

    Article • Biomeditsinskaya Khimiya, January 2016, Institute of Biochemistry

    Vasily N Sukhorukov

  71. Atherogenic modification of low-density lipoproteins

    Article • Biomeditsinskaya Khimiya, January 2016, Institute of Biochemistry

    Vasily N Sukhorukov

  72. Neuron density in the hippocampus in rat strains with contrasting nervous system excitability after prolonged emotional-pain stress

    Article • Neuroscience and Behavioral Physiology, May 2008, Springer Science + Business Media

    Vasily N Sukhorukov